|
|||||
|
|
Treatment of metastatic renal carcinoma patients with the combination of gemcitabine,capecitabine and bevacizumab at a tertiary cancer centre |
|
| Authors: | Eric Jonasch Lincy S Lal Bradley J Atkinson Stacey DaCosta Byfield Lesley Ann Miller Lance C Pagliaro Chun Feng Nizar M Tannir |
| Institution: | 1. Genitourinary Medical Oncology;2. Clinical Pharmacy Services, Division of Pharmacy, University of Texas M. D. Anderson Cancer Center, Houston, TX;3. Health Economics and Outcomes, i3 Innovus, Eden Prairie, MN;4. US Outcomes Research, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA |
| Abstract: | |
| Keywords: | renal cell carcinoma RCC chemotherapy gemcitabine capecitobine bevacizumab |